Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: 2022 report, https://goldcopd.org/2022-gold-reports-2/
Hanania N.A. & O'Donnell D.E. (2019). ‘Activity-related dyspnea in chronic obstructive pulmonary disease: physical and psychological consequences, unmet needs, and future directions’. International Journal of Chronic Obstructive Pulmonary Disease; 14: 1127–1138, https://doi.org/10.2147/COPD.S188141
Parshall M.B., Schwartzstein R.M., Adams L., Banzett R.B., Manning H.L., Bourbeau J., Calverley P.M., Gift A.G., Harver A., Lareau S.C., Mahler D.A., Meek P.M. & O’Donnell D.E. (2012). ‘An Official American Thoracic Society Statement: Update on the Mechanisms, Assessment, and Management of Dyspnea’. American Journal of Respiratory & Critical Care Medicine; 185(4): 435–452, https://doi.org/10.1164/rccm.201111-2042ST
Miravitlles M. & Ribera A. (2017). ‘Understanding the impact of symptoms on the burden of COPD’. Rwspiratory Research; 18(1): 67, https://doi.org/10.1186/s12931-017-0548-3
Kazeminasab S., Emamalizadeh B., Khoubnasabjafari M. & Jouyban A. (2021). ‘Exhaled Breath Condensate: A Non-Invasive Source for Tracking of Genetic and Epigenetic Alterations in Lung Diseases’. Pharmaceutical Sciences; 27(2): 149–161, https://doi.org/10.34172/PS.2020.46
Kostikas K., Papatheodorou G., Psathakis K., Panagou P. & Loukides S. (2003). ‘Oxidative Stress in Expired Breath Condensate of Patients With COPD’. Chest; 124: 1373–1280, https://doi.org/10.1378/chest.124.4.1373
Murata K., Fujimoto K., Kitaguchi Y., Horiuchi T., Kubo K. & Honda T. (2014). ‘Hydrogen Peroxide Content and pH of Expired Breath Condensate from Patients with Asthma and COPD’. COPD Journal of Chronic Obstructive Pulmonary Disease; 11: 81–87, https://doi.org/10.3109/15412555.2013.830094
Inonu H., Doruk S., Sahin S., Erkorkmaz U., Celik D., Celikel S. & Seyfikli Z. (2012). ‘Oxidative Stress Levels in Exhaled Breath Condensate Associated With COPD and Smoking’. Respiratory Care; 57(3): 413–419, https://doi.org/10.4187/respcare.01302
Makris D., Paraskakis E., Korakas P., Karagiannakis E., Sourvinos G., Siafakas N.M. & Tzanakis N. (2008). ‘Exhaled Breath Condensate 8-Isoprostane, Clinical Parameters, Radiological Indices and Airway Inflammation in COPD’. Respiration; 75: 138–144, https://doi.org/10.1159/000106377
Rahimpour E., Khoubnasabjafari M., Jouyban-Gharamaleki V. & Jouyban A. (2018). ‘Non-volatile compounds in exhaled breath condensate: review of methodological aspects’. Analytical and Bioanalytical Chemistry; 410(25): 6411–6440. https://doi.org/10.1007/s00216-018-1259-4
Horváth I., Barnes P.J., Loukides S., Sterk P.J., Högman M., Olin A.C., Amann A., Antus B., Baraldi E., Bikov A., Boots A.W., Bos L.D., Brinkman P., Bucca C., Carpagnano G.E., Corradi M., Cristescu S., de Jongste J.C., Dinh-Xuan A.T., Dompeling E., Fens N., Fowler S., Hohlfeld J.M., Holz O., Jöbsis Q., Van De Kant K., Knobel H.H., Kostikas K., Lehtimäki L., Lundberg J.O., Montuschi P., Van Muylem A., Pennazza G., Reinhold P., Ricciardolo F.L.M., Rosias P., Santonico M., Van der Schee M.P., Van Schooten F.J., Spanevello A., Tonia T. & Vink T.J. (2017). ‘A European Respiratory Society technical standard: exhaled biomarkers in lung disease’. European Respiratory Journal; 49: 1600965, https://doi.org/10.1183/13993003.00965-2016
ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories (2002). ‘ATS statement: guidelines for the six-minute walk test’. American Journal of Respiratory & Critical Care Medicine; 166(1): 111–7, https://doi.org/10.1164/ajrccm.166.1.at1102
Modified Borg dyspnea scale. https://www.physio-pedia.com/Physiopedia:About
COPD Assessment Test user guide. https://www.catestonline.org/content/dam/global/catestonline/documents/CAT_HCP%20User%20Guide.pdf
Maniscalco M., Fuschillo S., Paris D., Cutignano A., Sanduzzi A. & Motta A. (2019). ‘Clinical metabolomics of exhaled breath condensate in chronic respiratory diseases’. Advances in Clinical Chemistry; 88: 121–149, https://doi.org/10.1016/bs.acc.2018.10.002
Lazar Z., Horvath I., Vestbo J. & Bikov A. (2018). ‘Exhaled breath condensate in chronic obstructive pulmonary disease: methodological challenges and clinical application’. Minerva Pneumologica; 57(2): 42–56, https://doi.org/10.23736/S0026-4954.18.01816-3
Lewthwaite H., Jensen D. & Ekström M. (2021). ‘How to Assess Breathlessness in Chronic Obstructive Pulmonary Disease’. International Journal of Chronic Obstructive Pulmonary Disease; 16: 1581–1598, https://doi.org/10.2147/COPD.S277523
Davis M.D., Fowler S.J. & Montpetit A.J. (2019). ‘Exhaled Breath Testing – A Tool for the Clinician and Researcher’. Paediatric Respiratory Reviews; 29: 37–41, https://doi.org/10.1016/j.prrv.2018.05.002
Ghio A.J., Madden M.C. & Esther Jr C.R. (2018). ‘Transition and post-transition metals in exhaled breath condensate’. Journal of Breath Research; 12(2): 027112, https://doi.org/10.1088/1752-7163/aaa214
Larstad M., Almstrand A.C., Larsson P., Bake B., Larsson S., Ljungström E., Mirgorodskaya E. & Olin A.C. (2015). ‘Surfactant Protein A in Exhaled Endogenous Particles Is Decreased in Chronic Obstructive Pulmonary Disease (COPD) Patients: A Pilot Study’. PLoS One; 10(12):e0144463, https://doi.org/10.1371/journal.pone.0144463
Schwarz K., Biller H., Windt H., Koch W. & Hohlfeld J.M. (2015). ‘Characterization of Exhaled Particles from the Human Lungs in Airway Obstruction’. Journal of Aerosol Medicine & Pulmonary Drug Delivery; 28(1):52–58, https://doi.org/10.1089/jamp.2013.1104
Seferaj S., Ullah S., Tinglev A., Carlsson S., Winberg J., Stambeck P. & Beck O. (2018). ‘Evaluation of a new simple collection device for sampling of microparticles in exhaled breath’. Journal of Breath Research; 12(3): 036005, https://doi.org/10.1088/1752-7163/aaaf24
Bake B., Larsson P., Ljungkvist G., Ljungström E. & Olin A.C. (2019). ‘Exhaled particles and small airways’. Respiratory Research; 20(1): 8, https://doi.org/10.1186/s12931-019-0970-9
Anzueto A. & Miravitlles M. (2017). ‘Pathophysiology of dyspnea in COPD’. Postgraduate Medicine; 129(3): 366–374, https://doi.org/10.1080/00325481.2017.1301190
Welker R.W. (2012). ‘Size Analysis and Identification of Particles’. Chapter 4th, In R. Kohli & K.L. Mittal (eds), Developments in Surface Contamination and Cleaning. Detection, Characterization, and Analysis of Contaminants, (pp. 179–213). William Andrew, https://doi.org/10.1016/B978-1-4377-7883-0.00004-3
Pawan K.C., Liu F., Zhe J. & Zhang G. (2018). ‘Development and Comparison of Two Immuno-disaggregation Based Bioassays for Cell Secretome Analysis’. Theranostics; 8(2): 328–340, https://doi.org/10.7150/thno.21917
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this paper
Cite this paper
Patsiris, S., Vaitsis, N., Nasoula, I., Exarchos, T., Vlamos, P. (2023). Detection and Quantification of Exhaled Breath Condensate and Dyspnea Correlation in Stable COPD: A Proof-of-Concept Study. In: Vlamos, P. (eds) GeNeDis 2022. GeNeDis 2022. Advances in Experimental Medicine and Biology, vol 1423. Springer, Cham. https://doi.org/10.1007/978-3-031-31978-5_3
Download citation
DOI: https://doi.org/10.1007/978-3-031-31978-5_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-31977-8
Online ISBN: 978-3-031-31978-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)